ÂÜÀòÂÒÂ×

Belinda Carlsen has a diverse and extensive work experience. Belinda is currently working as the VP of Clinical Operations at LEUCID BIO since May 2022. Prior to this, they held the position of Head of Clinical Development at Cell and Gene Therapy Catapult from May 2019 to May 2022. Belinda also worked as a Clinical Research Consultant at QBCM Limited from June 2008 to June 2019. Additionally, Belinda worked as a Clinical Study Manager (contract) at Kite Pharma, Inc. from November 2017 to May 2019. Belinda served as a Clinical Research Study Lead (contract) at Roche from June 2015 to November 2017. Belinda also worked as a Clinical Operations Manager (contract) at ONO PHARMA UK LTD from March 2014 to June 2015 and at Psioxus Therapeutics from January 2014 to May 2014. Prior to that, they held the position of Clinical Operations Manager (contract) at ONO PHARMA UK LTD from July 2013 to November 2013. Belinda also worked as a Clinical Project Manager (contract) at Roche Pharmaceuticals from August 2010 to June 2013. Belinda started their career as a Director at the United Kingdom Roller Derby Association (UKRDA), serving in that role from an unspecified start date to December 2012. Belinda's work experience emphasizes their expertise in clinical operations, project management, and leadership roles.

Belinda Carlsen's education history is as follows:

From 2018 to 2020, Belinda attended Birkbeck, University of London, where they pursued a Master of Science (MSc) degree in Bio-business.

Prior to that, they studied at the same institution from 2004 to 2008 and obtained a Bachelor of Science (BSc) degree in Biological Sciences.

In 2003, Belinda briefly attended Holmesglen Institute of TAFE, where they completed a Certificate IV in Assessment & Workplace Training.